摘要
文章通过文献和报道对羟乙基淀粉系列原料的分类、临床不良反应关联关键质量指标的控制、研究情况进行简述,并强调羟乙基淀粉系列原料药质量标准统一的重要性。
This paper briefly described the classification of a series of hydroxyethyl starch APIs, clinical adverse reactions associated with key indicators of quality control and research situations according to the literature and reports.Moreover,it emphasized the importance of unified quality standards of a series of hydroxyethyl starch APIs.
作者
齐麟
陈仁萍
连传宝
尹建峰
QI Lin CHEN Renping LIAN Chuanbao YIN Jianfeng(Shandong Qidu Pharmaceutical Co., Ltd., Linzi 255400, China Shandong Provincial Key Laboratory of Neuroprotective Drugs, Zibo 255400, China Zibo Food and Drug Administration, Zibo 255400, China Zibo Linzi Food and Drug Administration, Linzi 255400, China)
出处
《药学研究》
CAS
2016年第12期734-736,共3页
Journal of Pharmaceutical Research